Report ID: SQMIG35H2169
Report ID:
SQMIG35H2169 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
173 |
Figures:
71
North America accounted for a large market share in 2022. This can be ascribed to the developed pharmaceutical and biotech sectors as well as the widespread use of innovative technology in the United States. There is a big market for cell separation technologies as a result of research universities' extensive activity in the field of cell treatments. Additionally, the growing incidence of chronic and infectious disorders, has increased the need for cell separation technologies for use in both research and therapeutic settings.
Asia Pacific is predicted to grow at a substantial CAGR during the forecast period owing to the expanding biotechnology and pharmaceutical sectors in developing nations like China and India. In addition, the category is anticipated to be driven throughout the forecast period by rising healthcare costs and increased market penetration by big international companies in important Asia Pacific nations. Additionally, ongoing stem cell and gene therapy research projects in Japan, China, and South Korea have increased the region's need for cell separation technologies.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35H2169